Arai T, Miyoshi Y, Kim SJ, Akazawa K, Maruyama N, Taguchi T, Tamaki Y, Noguchi S (2008) Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers. Eur J Surg Oncol 34:734–738. https://doi.org/10.1016/j.ejso.2007.07.008

Article  CAS  PubMed  Google Scholar 

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297. https://doi.org/10.1016/s0092-8674(04)00045-5

Article  CAS  PubMed  Google Scholar 

Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674–690. https://doi.org/10.1038/nrclinonc.2016.66

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072. https://doi.org/10.1016/j.cell.2012.03.042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garzon R, Calin GA, Croce CM (2009) Micrornas in cancer. Annu Rev Med 60:167–179. https://doi.org/10.1146/annurev.med.59.053006.104707

Article  CAS  PubMed  Google Scholar 

He Y, Ling Y, Zhang Z, Mertens RT, Cao Q, Xu X, Guo K, Shi Q, Zhang X, Huo L et al (2023) Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression. Redox Biol 65:102822. https://doi.org/10.1016/j.redox.2023.102822

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Q, Dai J, Zhang Z, Yu H, Zhang J, Zhu X, Qin Y, Zhang L, Zhang P (2023) ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells. Cancer Res 83:1646–1665. https://doi.org/10.1158/0008-5472.Can-22-1999

Article  CAS  PubMed  Google Scholar 

Iorio MV, Croce CM (2012) Microrna involvement in human cancer. Carcinogenesis 33:1126–1133. https://doi.org/10.1093/carcin/bgs140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lei G, Zhuang L, Gan B (2022) Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 22:381–396. https://doi.org/10.1038/s41568-022-00459-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lei X, Du L, Yu W, Wang Y, Ma N, Qu B (2021) GSTP1 as a novel target in radiation induced lung injury. J Transl Med 19:297. https://doi.org/10.1186/s12967-021-02978-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li R, Xu T, Wang H, Wu N, Liu F, Jia X, Mi J, Lv J, Gao H (2019) Dysregulation of the miR-325-3p/DPAGT1 axis supports HBV-positive HCC chemoresistance. Biochem Biophys Res Commun 519:358–365. https://doi.org/10.1016/j.bbrc.2019.08.116

Article  CAS  PubMed  Google Scholar 

Li R, Zheng JZ, Huang X (2020) Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis. Eur Rev Med Pharmacol Sci 24:9303–9314. https://doi.org/10.26355/eurrev_202009_23012

Article  CAS  PubMed  Google Scholar 

Liao L, Zhang YL, Deng L, Chen C, Ma XY, Andriani L, Yang SY, Hu SY, Zhang FL, Shao ZM et al (2023) Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer Res 83:471–484. https://doi.org/10.1158/0008-5472.Can-22-2709

Article  CAS  PubMed  Google Scholar 

Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM, Brem H (2007) Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6:609–621. https://doi.org/10.1517/14740338.6.5.609

Article  CAS  PubMed  Google Scholar 

Miyake T, Nakayama T, Naoi Y, Yamamoto N, Otani Y, Kim SJ, Shimazu K, Shimomura A, Maruyama N, Tamaki Y et al (2012) GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci 103:913–920. https://doi.org/10.1111/j.1349-7006.2012.02231.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel G, Prince A, Harries M (2024) Advanced triple-negative breast cancer. Semin Oncol Nurs 40:151548. https://doi.org/10.1016/j.soncn.2023.151548

Article  PubMed  Google Scholar 

Sell MC, Ramlogan-Steel CA, Steel JC, Dhungel BP (2023) Micrornas in cancer metastasis: biological and therapeutic implications. Expert Rev Mol Med 25:e14. https://doi.org/10.1017/erm.2023.7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273–285. https://doi.org/10.1016/j.cell.2017.09.021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun T, Li K, Zhu K, Yan R, Dang C, Yuan D (2020) SNHG6 interacted with miR-325-3p to regulate cisplatin resistance of gastric cancer by targeting GITR. Onco Targets Ther 13:12181–12193. https://doi.org/10.2147/ott.S262896

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan X, Huang X, Niu B, Guo X, Lei X, Qu B (2022) Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: existing evidence and future directions. Front Mol Biosci 9:1102158. https://doi.org/10.3389/fmolb.2022.1102158

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang SQ, Chen JJ, Jiang Y, Lei ZN, Ruan YC, Pan Y, Yam JWP, Wong MP, Xiao ZJ (2023a) Targeting GSTP1 as therapeutic strategy against lung adenocarcinoma stemness and resistance to tyrosine kinase inhibitors. Adv Sci (Weinh) 10:e2205262. https://doi.org/10.1002/advs.202205262

Article  CAS  PubMed  Google Scholar 

Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H (2023b) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 66:100916. https://doi.org/10.1016/j.drup.2022.100916

Article  CAS  PubMed  Google Scholar 

Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165–176. https://doi.org/10.1016/j.tcb.2015.10.014

Article  CAS  PubMed  Google Scholar 

Yi M, Peng C, Xia B, Gan L (2022) CXCL8 facilitates the survival and paclitaxel-resistance of triple-negative breast cancers. Clin Breast Cancer 22(2):e191–e198. https://doi.org/10.1016/j.clbc.2021.06.009

Article  CAS  PubMed  Google Scholar 

Zhang L, Chen H, Song Y, Gu Q, Zhang L, Xie Q, Xu J, Zhang M (2021) MiR-325 promotes oxaliplatin-induced cytotoxicity against colorectal cancer through the HSPA12B/PI3K/AKT/Bcl-2 pathway. Dig Dis Sci 66:2651–2660. https://doi.org/10.1007/s10620-020-06579-7

Article  CAS  PubMed  Google Scholar 

Zhang W, Dai J, Hou G, Liu H, Zheng S, Wang X, Lin Q, Zhang Y, Lu M, Gong Y et al (2023) SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol Cell 83:4352-4369.e4358. https://doi.org/10.1016/j.molcel.2023.10.042

Article  CAS  PubMed  Google Scholar 

Zhu H, Jiang CW, Zhang WL, Yang ZY, Sun G (2024) Targeting oncoge